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ABSTRACT  
The present study investigates the effect of isopulegol on adipokine secretion and dyslipidemia in high fat diet and streptozotocin (HFD/STZ) 
induced diabetic rats. Animals were made diabetic by feeding HFD for 4 wks followed by single intraperitoneal injection of STZ (35mg/kg b.w; 
0.1M citrate buffer; pH 4.0). Diabetic rats showed increased levels of total cholesterol, triglycerides, free fatty acids, phospholipids, low density 
lipoprotein-C (LDL-C), very low density lipoprotein -C (VLDL-C) and decreased high density lipoprotein-C levels (HDL-C). Similarly, the activity 
of HMG-CoA reductase, was increased while lipoprotein lipase (LPL) and lecithin cholesterol acyl transferase (LCAT) activities were 
significantly decreased. Furthermore, the expression of sterol regulatory element binding protein-1C (SREBP-1C), adiponectin, peroxisome 
proliferator activated receptor gamma (PPARγ) were significantly down regulated, whereas leptin expression was upregulated in diabetic rats. 
Administration of isopulegol (100 mg/kg b.w) for 28 days signiﬁcantly restored lipid levels in plasma and liver tissue by modulating adipokine 
secretion in diabetic treated rats. From this we conclude that isopulegol exhibited significant antihyperlipidemic effect in HFD/STZ induced 
diabetic rats. 
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1.    INTRODUCTION 
Diabetic dyslipidemia in type 2 diabetes mellitus is 
characterised by a cluster of lipid and lipoprotein 
abnormalities which is an important risk factor for coronary 
artery disease and stroke. High fat diet and oxidative 
damage contributes to the development of dyslipidemia and 
impairs insulin signaling in diabetes mellitus [1]. Lack of 
responsiveness and an inability to control hyperlipidaemia 
are the drawbacks associated with the long term use of the 
currently available antidiabetic drugs Controlling 
dyslipidemia is of prime importance in preventing 
cardiovascular risk in diabetes mellitus. The rationale use of 
phytochemicals offers hope for a more effective drug in the 
management of diabetes mellitus.  
Isopulegol a naturally occurring monoterpene is widely 
distributed in grape fruit, mint, rosemary oil and possess 
numerous pharmacological properties [2]. Recently, we 
reported that isopulegol regulated the activities of 
carbohydrate metabolic enzymes and improved insulin 
secretion in high fat diet (HFD)/streptozotocin (STZ) 
induced diabetic rats [3] . In this context the present study 
was designed to investigate the potential role of isopulegol 
on dyslipidemia, and on adipokine levels in HFD/STZ 
induced diabetic rats 
2.   MATERIALS AND METHODS: 
2.1.   Chemicals and drugs 
Isopulegol and STZ were purchased from Sigma Aldrich Pvt. 
Ltd., (St.Louis, MO,USA). Diagnostic kits for cholesterol and 
triglycerides were purchased from Agappe diagnostics Ltd, 
Kerala, India. All other chemicals used in this study were of 
analytical grade and obtained from SD fine and HIMEDIA, 
India. 
2.2.   Ethical statement for animal experimentation 
Thirty adult male wistar rats with body weight ranging from 
180 to 200 g were purchased from National Centre for 
Laboratory Animal Science, Bangalore. They were housed in 
well-ventilated cages (temperature 23 ± 2 °C, humidity 65-
70% and 12 h light/dark cycle), fed on pellet diet and water 
ad libitum. Studies were carried out in accordance with 
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Indian National Law on Animal Care and Use and were 
approved by the Institutional ethical committee (Proposal 
No.1000) of Rajah Muthiah Medical College and Hospital, 
Annamalai University, India. 
2.3    Development of type 2 diabetes mellitus 
Rats divided into five groups with six in each group were 
placed under normal pellet diet and water for a week prior 
to dietary manipulation. Experimental animals in three 
groups were fed with a HFD (40%) for 4 weeks. This was 
followed by a single intraperitoneal injection of freshly 
prepared STZ (35 mg/kg b.w) dissolved in 0.1M citrate 
buffer (pH 4.5). After one week, fasting blood glucose levels 
were determined and rats with glucose levels > 250 mg/dl 
were considered as diabetic and used in this study.
 
 
2.4.   Experimental design 
Animals were grouped and treated as follows. 
Group I : Control rats fed with normal pellet diet 
Group II : Control rats fed with normal pellet diet and administered p.o with an aqueous solution of isopulegol (200 
mg/kg b.w).  
Group III : Diabetic rats fed with high fat diet 
Group IV : Diabetic rats administered p.o with an aqueous solution of isopulegol (100 mg/kg b.w).  
Group V : Diabetic rats administered p.o with an aqueous solution of metformin (25 mg/kg b.w).  
 
 
2.5.   Extraction and assay of lipids 
Lipid extraction from tissues were carried out by the method 
of Folch et al [4].  By adopting suitable methods the levels of 
TC [5], HDL-C [6], LDL-C & VLDL-C [7], TG [8], FFA [9], PL 
[10], LPL and LCAT activity [11, 12] were measured.   
2.6.   Western blotting analysis 
The expression pattern of adiponectin and leptin were 
analysed in the adipose tissue [13]. 
2.7.  Histological examination 
Haematoxylin and eosin staining of adipose tissue was 
performed as described by Hine [14]. 
2.8.   Quantitative real time -PCR (q RT-PCR)  
Total RNA was extracted using TRIzol reagent (Invitrogen 
Bioservices India Pvt. Ltd) according to the manufacturer's 
instructions. The reverse transcription reaction was 
conducted using miScript Reverse Transcription Kit (Genei, 
India). Real-time PCR was conducted on the PCR System 
with SYBR Premix Ex Taq (Bangalore, India) 
 
 
The primers sequences used are as follows: 
Gene Accession number Primer 
PPARγ    O88275 F : 5' GGAATGGGAGTGGTCATCCA3' 
  R : 5' CCCACCAACTTCGGAATC3' 
SREBP-1C     P56720 F : 5' GCTCAGGGTGCCAGCGAACCAGTG3' 
  R : 5' GGGTTACTAGCGGACGTCCGCC3' 
GAPDH PO4797                   F:   5' AAGGGGAACCCTTGATATGG 3' 
R: 5' GGGAGATGATGATGACCCTTTT 3' 
 
 
2.9.   Statistical analysis 
All data were expressed as mean ± S.D of number of 
experiments (n = 5). The statistical significance was 
evaluated by one-way analysis of variance (ANOVA) using 
SPSS version 20 (SPSS, Cary, NC, USA) and the individual 
comparison were obtained by Duncan’s multiple range test 
(DMRT). 
 
 
3. RESULTS 
3.1.  Influence of isopulegol on circulating lipids 
Table1 shows the levels of TC, TGs, PLs, FFAs in plasma of 
control and experimental rats. Diabetic rats showed 
significantly elevated levels of  TC, TGs, FFAs and PLs levels 
when compared with normal rats. Oral administration of 
isopulegol (100 mg/kg b.w)  for 28 days to diabetic rats 
significantly reduced the levels of above lipids when 
compared to diabetic rats. These findings are comparable 
with metformin treated diabetic rats. 
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Table 1: Effect of isopulegol on the levels of TC, TGs, FFAs and PLs in the plasma of normal and experimental rats 
Groups TC (mg/dl) TGs (mg/dl) FFAs (mg/dl) PLs (mg/dl) 
Normal 95.21 ± 7.25a 80.61 ± 6.13 a 63.31 ± 4.82 a 85.21 ± 6.49 a 
Normal+isopulegol (200mg/kg 
b.w) 
96.04 ± 7.35 a 85.24 ± 6.52 a 62.03 ± 4.74 a 76.34 ± 5.84 a 
Diabetic (HFD/STZ) 167.28 ± 12.80 b 154.37 ± 11.81 b 130.16 ± 9.96 b 150.27 ± 11.50 b 
Diabetic+isopulegol (100mg/kg 
b.w) 
120.36 ± 9.21c 110.25 ± 8.44 c 80.64 ± 6.17 c 108.25 ± 8.28 c 
Diabetic + metformin    (25 
mg/kg b.w) 
108.52 ± 8.26d 95.51 ± 7.27 d 72.81 ± 5.54 d 97.61 ± 7.43 d 
Values are expressed as mean ± SD for six rats. Values not sharing a common superscript (a-d) differ significantly at P<0.05 
(DMRT)  
 
3.2.   Effect of isopulegol on lipid profile in hepatic tissue 
The levels of TC, FFA, PL and TG in hepatic tissue of control 
and experimental rats  were shown in Table 2. Diabetic rats 
exhibited a significant increase in the lipid content 
compared to normal rats. Administration of isopulegol to 
diabetic rats significantly reversed the lipid content in 
hepatic tissue to near normal. 
 
Table 2: Effect of isopulegol on the levels of TC, TGs, FFAs and PLs in the hepatic tissue of normal and experimental rats 
Groups TC (mg/dl) TGs (mg/dl) FFAs (mg/dl) PLs (mg/dl) 
Normal 5.60 ± 0.42 a 4.05 ± 0.30 a 18.05 ± 1.37a 21.50 ± 1.63 a 
Normal+ isopulegol (200mg/kg b.w) 5.30 ± 0.40 a 4.10 ± 0.31a 17.04 ± 1.30 a 20.62 ± 1.57 a 
Diabetic (HFD/STZ) 9.80 ± 0.74 b 7.90 ± 0.60 b 30.91 ± 2.36 b 38.82 ± 2.96 b 
Diabetic+ isopulegol (100mg/kg b.w) 7.70 ± 0.58c 6.70 ± 0.51 c 22.81 ± 1.74 c 30.71 ± 2.35 c 
Diabetic + metformin (25 mg/kg b.w) 6.90 ± 0.52d 5.80 ± 0.43 d 20.70 ± 1.57 d 26.80 ± 2.03 d 
Values are expressed as mean ± SD for six rats. Values not sharing a common superscript (a-d) differ significantly at P<0.05 
(DMRT) 
 
3.3.  Effect of isopulegol on lipoprotein cholesterol in 
plasma 
 Table 3 depict the levels of lipoproteins cholesterol (HDL-C, 
LDL-C and VLDL-C) in the plasma of normal and 
experimental rats. The level of HDL-C was decreased 
whereas the levels of LDL-C and VLDL-C were significantly 
increased in diabetic rats when compared to normal control. 
Administration of isopulegol (100mg/kg b.w) decreased the 
levels of LDL-C, VLDL-C and significantly improved HDL-C 
levels in diabetic treated rats. The results are comparable 
with metformin (25mg/kg b.w) treated groups. 
 
Table 3: Effect of isopulegol on the levels of HDL-C, LDL-C, VLDL-C in the plasma of normal and experimental rats 
Groups HDL-C (mg/dl) LDL-C (mg/dl) VLDL-C (mg/dl) 
Normal 48.00 ± 3.65 a 38.00 ± 2.89 a 18.20 ± 1.38 a 
Normal+ isopulegol (200mg/kg b.w) 47.02 ± 3.59 a 36.71 ± 2.81 a 19.11 ± 1.46 a 
Diabetic (HFD/STZ) 24.61 ± 1.88 b 90.24 ± 6.91 b 32.51 ± 2.48 b 
Diabetic+ isopulegol (100mg/kg b.w) 34.61 ± 2.64 c 50.92 ± 3.89 c 25.61 ± 1.95 c 
Diabetic + metformin (25 mg/kg b.w) 40.50 ± 3.08 d 43.70 ± 3.32 d 21.80 ± 1.65 d 
Values are expressed as mean ± SD for six rats. Values not sharing a common superscript (a-d) differ significantly at P<0.05 
(DMRT)  
 
3.4.   Role of isopulegol on the activites of LPL and LCAT in 
plasma 
The activites of LCAT and LPL in plasma of normal control  
and experimental rats were shown in Table 4. Decreased 
activites of LCAT and LPL were observed in the plasma of 
diabetic rats as compared to normal rats. Administration of 
isopulegol (100 mg/kg b.w) and metformin (25mg/kg b.w) 
to diabetic rats significantly increased the activites of LCAT 
and LPL towards near normal. 
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Table 4: Effect of isopulegol on the activities of plasma LPL and LCAT of normal and experimental rats 
Groups 
LPL (μ moles of glycerol  
liberated /h/l) 
LCAT    (μ moles of 
cholesterol esterified/h/l) 
Normal 8.20 ± 0.62 a 86.21 ± 6.56 a 
Normal+ isopulegol (200mg/kg b.w) 7.30 ± 0.55 a 87.39 ± 6.68 a 
Diabetic (HFD/STZ) 4.50 ± 0.34 b 50.82 ± 3.88 b 
Diabetic+ isopulegol (100mg/kg b.w) 5.70 ± 0.43 c 65.73 ± 5.03 c 
Diabetic + metformin (25 mg/kg b.w) 6.85 ± 0.52 d 75.91 ± 5.77 d 
Values are expressed as mean ± SD for six rats. Values not sharing a common superscript (a-d) differ significantly at P<0.05 
(DMRT) 
3.5   Effect of isopulegol on the activity of HMG-COA 
reductase in hepatic tissue  
Figure 1 shows the activity of HMG-COA reductase in control 
and experimental animals. The activity of HMG-COA 
reductase was increased significantly in hepatic tissue of 
diabetic rats. Oral administration of Isopulegol as well as 
metformin to diabetic rats significantly decreased the 
activity of HMG-COA reductase in these tissue when 
compared to diabetic control rats. 
 
Figure 1: Effect of isopulegol on the activity of HMG-COA reductase in hepatic tissue of control and experimental rats 
Values are expressed as mean ± SD for six rats. Values not sharing a common superscript (a-d) differ significantly at p<0.05 
(DMRT). 
 
3.6   Role of isopulegol on the expression of adiponectin 
and leptin  
Figures 2 and 3 depicts the protein expression pattern of 
adiponectin and leptin in the adipose tissue of experimental 
rats. Significant downregulation of adiponectin with an 
upregulation of leptin expression was observed in diabetic 
control rats. Isopulegol (100 mg/kg b.w) treated diabetic 
rats significantly restored the protein expression pattern in 
the adipose tissue. 
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Figure 2: Effect of isopulegol on adiponectin protein expression in the adipose tissue of normal and experimental rats 
A. Western blot analysis 
               
  
 
 
Lane 1: Normal; Lane 2: Normal+ isopulegol (200mg/kg b.w); Lane 3: Diabetic (HFD/STZ); Lane 4: Diabetic+ isopulegol 
(100mg/kg b.w); Lane 5: Diabetic + metformin (25 mg/kg b.w) 
 
B. Band intensity scanned by densitometer 
 
Histograms depicts quantization of three independent experiments (mean ± S.D), with data normalized by defining the control 
group with adiponectin, as 1 unit. Values are not sharing a common superscript differ significantly at p<0.05 (DMRT) 
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Figure 3: Effect of isopulegol on leptin protein expression in the adipose tissue of normal and experimental rats 
A. Western blot analysis 
 
 
 
 
Lane 1: Normal; Lane 2: Normal+ isopulegol (200mg/kg b.w); Lane 3: Diabetic (HFD/STZ); Lane 4: Diabetic+ isopulegol 
(100mg/kg b.w); Lane 5: Diabetic + metformin (25 mg/kg b.w) 
 
B. Band intensity scanned by densitometer 
 
Histograms depicts quantization of three independent experiments (mean ± S.D), with data normalized by defining the control 
group with adiponectin, as 1 unit. Values are not sharing a common superscript differ significantly at p<0.05 (DMRT) 
 
3.7.  Effect of isopulegol on mRNA expression of PPAR γ 
and SREBP-1C  in diabetic rats 
The effect of isopulegol on the mRNA expression of PPAR γ 
and SREBP-1C in the adipose tissue of diabetic rats are 
shown in (Figures 4 – 6). The levels of PPARγ mRNA 
expression was significantly down regulated whereas 
SREBP-1C mRNA expression were significantly up regulated 
in diabetic  rats compared to  control rats. Treatment with 
isopulegol (100mg/kg b.w) significantly modulated PPARγ 
and SREBP-1C mRNA expression to near normal in treated 
diabetic rats compared to metformin treated rats.  
 
 
 
a a 
b 
c 
d 
0
0.2
0.4
0.6
0.8
1
1.2
Normal Normal+ isopulegol
(200mg/kg b.w)
Diabetic (HFD/STZ) Diabetic+ isopulegol
(100mg/kg b.w)
Diabetic + metformin
(25 mg/kg b.w)
R
e
la
ti
v
e
 a
r
b
it
r
a
r
y
 u
n
it
 (
F
o
ld
 i
n
c
r
e
a
se
) 
Leptin 
1 2 3 4 5 Lane 
Leptin 
25kDa 
β-actin 42kDa 
Kalaivani et al                                                                                                    Journal of Drug Delivery & Therapeutics. 2019; 9(4-A):126-136 
ISSN: 2250-1177                                                                                  [132]                                                                                 CODEN (USA): JDDTAO 
 
Figure 4: Analysis of PPARγ expression by qRT-PCR in adipose tissue of experimental rats 
 
q-RT-PCR analysis graph. b) PPARγ mRNA expression by q-RT-PCR in adipose tissue. Experiments were carried out in 
triplicates and data expressed are mean ± SD of 6rats from each group. The Ct values of the test gene of each group were 
standardized using Ct value of GAPDH of the same group. Values are expressed relative to those control rats that were 
arbitrarily assigned a value of 1.0. 
Figure 5 : Analysis of SREBP-1C expression by qRT-PCR in adipose tissue of experimental rats 
 
q-RT-PCR analysis graph. b) SREBP-1C mRNA expression by q-RT-PCR in adipose tissue. Experiments were carried out in 
triplicates and data expressed are mean ± SD of 6rats from each group. The Ct values of the test gene of each group were 
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standardized using Ct value of GAPDH of the same group. Values are expressed relative to those control rats that were 
arbitrarily assigned a value of 1.0. 
Figure 6: Analysis of SREBP-1C expression by qRT-PCR in the liver of experimental rats 
 
 
q-RT-PCR analysis graph. b) SREBP1-C mRNA expression by 
q-RT-PCR in liver tissue. Experiments were carried out in 
triplicates and data expressed are mean ± SD of 6rats from 
each group. The Ct values of the test gene of each group were 
standardized using Ct value of GAPDH of the same group. 
Values are expressed relative to those control rats that were 
arbitrarily assigned a value of 1.0. 
3.8.   Histology 
 Histological observations of haematoxylin-eosin-stained 
adipose tissue of control and treated rats are shown in 
(Figure.7). Diabetic rats showed swollen arrangement of 
cells in the epididymal adipose tissue. Oral administration of 
isopulegol (100mg/kg b.w) restored the architecture of 
adipose tissue to near normal.  
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Figure 7: Histopathological changes in adipose tissue of normal and  experimental  rats 
 
 
4.    DISCUSSION 
Increasing availability of energy dense food and sedentary 
lifestyle have led to a worldwide epidemic of type 2 diabetes 
mellitus. Dyslipidemia is a common biochemical feature in 
T2DM and is one of the major risk factors for cardiovascular 
and peripheral vascular disease (CVD) [15]. Insulin 
deficiency/resistance contributes to quantitative and 
qualitative lipid abnormalities with a shift towards 
atherogenic lipid profile that result in microvascular and 
macrovascular disorders.   
Free fatty acids are products of fat metabolism in adipose 
tissues and it is the main circulating lipid fuel in the post-
absorptive state. The mobilization of free fatty acids from 
stored TG occurs sequentially and requires the activation of 
hormone sensitive lipase (HSL), a key enzyme considered as 
crucial in regulating lipolysis in fat cells [16]. This enzyme is 
under tight hormonal and neuronal control and it has been 
found that variations in HSL expression modulate lipolysis in 
adipose tissue. In the diabetic state, insulin deficiency causes 
activation of HSL that results in hydrolysis of TG with 
concomitant release of large amounts of free fatty acids in 
circulation.  
Hypertriglyceridemia is a common finding in diabetic 
patients and is responsible for vascular complications. Lipid 
accumulation in hepatic tissue is mediated through a variety 
of derangements in metabolic and regulatory processes 
leading to hypercholesterolemia and hypertriglyceridemia 
[17].In the diabetic state, insulin deficiency increases 
mobilization of fatty acids from adipose tissue which are 
channelized to liver and esterified resulting in 
hypertriglyceridemia [18].  
Furthermore, lipoprotein lipase (LPL) catalyses the 
hydrolysis of the triglyceride component of chylomicrons, 
VLDL and provides non-esterified fatty acids and 2-
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monoacylglycerol for tissue utilisation. In diabetes mellitus, 
due to insulin deficiency the expression and activity of LPL is 
decreased resulting in impaired metabolism of TG rich 
lipoproteins leading to hypertriglyceridemia. We observed 
an increase in FFA, TG and LPL activity in HFD/STZ diabetic 
rats.  
Sterol regulatory element (SREBPs) transcription factor 
regulate the expression of lipogenic genes, such as fatty acid 
synthase and acetyl-CoA carboxylase, involved in lipid 
biosynthesis and uptake [19] . Studies have shown that 
increased expression of SREBP-1C accelerate TG 
accumulation in diabetic rats [20]. We observed an 
upregulation in the mRNA expression of SREBP-1C in the 
hepatic and adipose tissue of diabetic rats.  
Cholesterol homeostasis is an important metabolic process 
which reflects a balance between numbers of complex/ 
interactive processes. The biosynthesis of cholesterol is 
regulated by the rate-limiting enzyme HMG-CoA reductase, 
which catalyzes production of mevalonic acid. Increased 
activity of HMG-CoA reductase results in the excessive 
production and accumulation of cholesterol leading to the 
formation of foam cells, a pre-requisite step in the 
development of atherosclerosis [21]. Insulin deficiency is 
associated with decreased HMG CoA/mevalonate ratio 
indicating increased enzyme activity. Numerous studies 
have highlighted that the activity of HMG-CoA reductase is 
increased in diabetic rats [22].  
Phospholipids are vital components of bio membranes that 
play an important role in the maintenance of cellular 
integrity, micro viscosity and survival. An elevation of FFA 
and cholesterol in diabetic rats, promote the synthesis of PLs 
[23]. PLs are susceptible substrates for oxygen and hydroxyl 
free radicals generated in diabetic state. In DM, chronic 
hyperglycemia alters fatty acids, lipids and decreases the 
activities of membrane-bound enzymes [24].We observed an 
increase in cholesterol, phospholipids and HMG CoA 
reductase activity in plasma and liver tissue of diabetic rats.  
In the present study, treatment with isopulegol (100mg/kg 
b.w) for 28 days was sufficient to produce a significant 
decrease in the levels of FFA, TC, TG, PL and in the mRNA 
expression of SREBP-1C in diabetic treated rats. Similarly, 
the observed increase in HMG-COA reductase and a decrease 
in LPL activity were restored to near normal in isopulegol 
treated diabetic rats. These results indicate that isopulegol 
has significant lipid lowering effect in diabetic treated rats. 
Our findings are in line with wang et al who reported that 
Inonotus obliques polysaccharides normalized lipid profile in 
streptozocin diabetic rats [25]. 
In diabetic state, alterations in lipoprotein patterns are 
accompanied by changes in variety of biochemical processes. 
The transport of TG from liver to extrahepatic tissues for 
utilization and storage is achieved by VLDL [26]. Increased 
free fatty acid flux from lipolysis under insulin resistant 
conditions results in excessive production of VLDLs in the 
liver. These particles are synthesized in the liver and contain 
apo B-100 as their apolipoprotein component. Insulin 
deficiency increases the flux of metabolites to liver leading 
to overproduction of VLDL and also enhances its secretion 
through regulating the turnover apoB100 [27]. This process 
is severely impaired in diabetes mellitus resulting in 
increased VLDL-C in circulation. 
LDL cholesterol (LDL-C) is central importance in evaluating 
the effects of lipid modifying therapies. The atherogenic 
properties of LDL particles are related to their ability to 
penetrate the arterial wall and make them susceptible to 
oxidation. Increased LDL-C may arise on glycosylation of the 
lysyl residue of apoprotein- B as well as from decreasing 
affinity for the LDL receptor. These modifications results in 
decreased clearance of LDL particles by LDL-receptor (LDL-
R) and contribute to their elevated plasma levels [28]. A 
positive correlation exists between the incidence of 
coronary atherosclerosis and the oxidative modification of 
LDL particles.  
HDL promotes the reverse transport of cholesterol from 
peripheral tissues to liver with the help of ABCA1 
transporter protein. The anti-atherogenic effect of HDL is 
due to its antioxidant/anti-inflammatory function, which is 
of great significance in DM . The antioxidant effect is related 
to the presence of HDL-linked proteins (apo-A1, lecithin: 
cholesterol acyltransferase (LCAT), platelet-activating factor 
acetyl hydrolase) and paraoxonase (PON). HDL also acts as a 
repository of apolipoproteins C and E and governs the 
metabolism of chylomicrons and VLDL. Apo A1, the major 
apo protein of HDL-C is glycated in uncontrolled diabetes 
and results in increased permission of HDL particles from 
circulation [29]. LCAT a key enzyme in HDL-C metabolism 
facilitates the transfer of a fatty acid from position 2 of 
lecithin to cholesterol to form cholesteryl esters. This allows 
the transfer of cholesteryl ester to the core of HDL particle 
rendering the continuous uptake of free cholesterol by HDL. 
A decrease in LCAT activity severely impairs HDL-C 
synthesis and TGs metabolism in diabetic rats [30]. 
We observed a significant increase in VLDL-C and LDL-C 
levels with a decrease in HDL-C level in the plasma of 
diabetic rats. A decreased activity of LCAT was observed in 
plasma of diabetic rats. Treatment with isopulegol 
(100mg/kg b.w) improved lipoprotein cholesterol levels and 
LCAT activity in diabetic treated rats. The hypolipidemic 
effect of isopulegol is attributed to a significant reduction in 
blood glucose concentration via enhanced insulin secretion. 
This enhancement in insulin, increase utilization of glucose 
and decreases the mobilization of FFA from fat depots. Our 
results are consistent with Antony et al (2016) who reported 
that myoinositol improved lipoprotein cholesterol levels and 
LCAT activity in HFD/STZ diabetic rats.  
Adiponectin, improves insulin sensitivity and regulates 
energy homeostasis. It has been shown that adiponectin 
activates AMP-activated protein kinase (AMPK) and reduces 
the expression of gluconeogenic genes and enhances insulin 
sensitivity both in skeletal muscle and liver [31]. It is 
suggested that adiponectin plays an important role in lipid 
metabolism by stimulating fatty acid oxidation in liver and 
muscle, decreases plasma triglycerides and enhances 
glucose metabolism. High-fat diet and STZ induced diabetes 
was accompanied by a reduction in plasma adiponectin 
levels [32]. 
Leptin, decreases food intake, body weight and modulates 
glucoses and fat metabolism. It targets pancreatic β-cell, 
modulates insulin expression and secretion[33] . It also 
influences lipid metabolism by preventing TG accumulation 
in peripheral tissues. It has been found out that leptin 
stimulates fatty acid oxidation through AMP-activated 
protein kinase (AMPK) and subsequently inhibits acetyl-CoA 
carboxylase (ACC) activity in the skeletal muscle [34]. 
Increased circulating levels of leptin have been found to be 
associated with obesity and in chronic consumption of high-
fat diet. Studies have reported that circulating levels of both 
leptin and lipids are increased on high fat feeding in 
C57BL/6J mice [35].  
Our study revealed a significant down regulation in the 
expression of PPARγ, adiponectin and an upregulation of 
leptin expression in the adipose tissue of diabetic rats. 
Histopathological studies of revealed hypertrophy and 
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infiltration of macrophages in adipose tissue suggesting 
profound dysfunction in HFD/STZ diabetic rats. 
Administration of  isopulegol and metformin to diabetic rats 
markedly restored changes in the expression levels of 
PPARγ, adiponectin and leptin in adipose tissue. The 
possible mechanism of isopulegol in the improvement of 
adipokines may be due to the activation of PPARγ  in the 
adipose tissue. Our findings are in agreement with Hosni et 
al the reported that cinnamaldehyde effectively improved 
insulin secretion and sensitivity by up regulation of PPARγ 
gene expression and diminishing the proinflammatory 
cytokines in diabetic rats [36]. 
5.  CONCLUSION 
From this we conclude that administration of isopulegol 
effectively regulated adipokine expression, restored the 
levels of lipids and lipoprotein cholesterol by regulating the 
activities of key enzymes and ameliorated dyslipidemia in 
diabetic rats. In addition, histopathological studies revealed 
a protective effect of isopulegol. Further studies are 
warranted to unravel the molecular action of isopulegol in 
controlling dyslipidemia in diabetes mellitus.  
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